From: Efficacy and safety of tacrolimus in older adults with ulcerative colitis: a retrospective study
Younger (< 65 yrs. old) n = 116 | Elderly (≥65 yrs. old) n = 21 | p-value | |
---|---|---|---|
Patients achieving remission (%) | 93 (80.1%) | 14 (66.6%) | 0.1862 |
Total adverse effects of TAC: | 40 | 8 | 0.7507 |
*tremor | 22 | 4 | 0.8426 |
*Headache | 2 | 2 | 0.0981 |
*nausea | 1 | 0 | 0.5632 |
*renal impairment | 14 | 4 | 0.4721 |
*hyperglycemia | 1 | 0 | 0.5632 |